Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:17 PM
Ignite Modification Date:
2025-12-24 @ 11:17 PM
NCT ID:
NCT07221656
Eligibility Criteria:
Inclusion Criteria:
* Acute lymphoblastic leukemia/lymphoma being treated by the pediatric hematology team
* Receiving calaspargase as part of treatment for malignancy
Exclusion Criteria:
* Age \> 21 years
* Patients who are actively enrolled on Children's Oncology Group (COG) trial AALL1732 in an inotuzumab containing arm
* Pregnancy
Healthy Volunteers:
False
Sex:
ALL
Maximum Age:
21 Years
Study:
NCT07221656
Study Brief:
Protocol Section:
NCT07221656